Novavax (NVAX) director granted RSUs and stock options in new equity awards
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
NOVAVAX INC director Charles W. Newton received new equity awards as part of his compensation. On June 18, 2026, he was granted 14,180 restricted stock units, each representing one share of Novavax common stock, and a stock option for 21,270 shares at an exercise price of $9.13 per share.
According to the company’s Amended and Restated 2015 Stock Incentive Plan, one hundred percent of the option shares will vest on the first anniversary of the June 18, 2026 grant date, subject to his continued service on the Board of Directors. The RSU grant is also described as vesting in full on the first anniversary of that grant date, under the same continued-service condition.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Newton Charles W.
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 21,270 | $0.00 | -- |
| Grant/Award | Restricted Stock Units | 14,180 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,270 shares (Direct, null);
Restricted Stock Units — 14,180 shares (Direct, null)
Footnotes (1)
- One hundred percent (100%) of the shares subject to this option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended, will vest on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Novavax, Inc. (the "Company") common stock. One hundred percent (100%) of the RSUs subject to this grant under the Company's Amended and Restated 2015 Stock Incentive Plan, as amended, vested on the first anniversary of the June 18, 2026 grant date subject to continued service on the Company's Board of Directors through the vesting date.
Key Figures
RSU grant size: 14,180 RSUs
Option grant size: 21,270 options
Option exercise price: $9.13 per share
+3 more
6 metrics
RSU grant size
14,180 RSUs
Granted to director Charles W. Newton on June 18, 2026
Option grant size
21,270 options
Stock Option (Right to Buy) granted June 18, 2026
Option exercise price
$9.13 per share
Conversion or exercise price for 21,270 stock options
Options expiration
June 18, 2036
Expiration date of the stock option grant
RSUs underlying common stock
14,180 shares
Underlying Novavax common stock for RSU grant
Options underlying common stock
21,270 shares
Underlying Novavax common stock for option grant
Key Terms
Restricted Stock Units, Stock Option (Right to Buy), Amended and Restated 2015 Stock Incentive Plan, exercise price, +1 more
5 terms
Restricted Stock Units financial
"security_title: "Restricted Stock Units""
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
Amended and Restated 2015 Stock Incentive Plan financial
"option grant under the Amended and Restated 2015 Stock Incentive Plan, as amended"
exercise price financial
"conversion_or_exercise_price: "9.1300""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest financial
"will vest on the first anniversary of the June 18, 2026 grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider transactions did NVAX director Charles W. Newton report?
Charles W. Newton reported receiving equity awards in the form of restricted stock units and stock options. The filing shows grants of 14,180 RSUs and 21,270 stock options tied to Novavax common stock, both awarded on June 18, 2026 under a company stock incentive plan.
How many restricted stock units did Charles W. Newton receive from NOVAVAX INC (NVAX)?
He received 14,180 restricted stock units. Each RSU represents a contingent right to receive one share of Novavax common stock, granted under the company’s Amended and Restated 2015 Stock Incentive Plan and subject to a service-based vesting condition tied to Board tenure.
What are the terms of the stock options granted to NVAX director Charles W. Newton?
Newton was granted stock options covering 21,270 shares of Novavax common stock at an exercise price of $9.13 per share. The filing states that 100% of the option shares will vest on the first anniversary of the June 18, 2026 grant date, contingent on continued Board service.
When do Charles W. Newton’s NOVAVAX INC equity awards vest?
Both the option and RSU awards are described as vesting one year after the June 18, 2026 grant date. Vesting is conditioned on Newton’s continued service on Novavax’s Board of Directors through that first anniversary, reflecting a typical time-based compensation structure.
Are Charles W. Newton’s NVAX Form 4 transactions open-market buys or compensation grants?
These transactions are compensation-related grants, not open-market purchases or sales. The Form 4 uses transaction code “A” for both, indicating grant or award acquisitions of RSUs and stock options under Novavax’s Amended and Restated 2015 Stock Incentive Plan, rather than discretionary trading.